Stay updated with breaking news from Single Pill. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
05.05.2022 APONTIS PHARMA and Develco Pharma enter development partnership for launch of two Single Pills with pan-European intellectual property rights | APONTIS PHARMA AG | News | Nachricht | Mitteilung
Investegate announcements from APONTIS PHARMA AG, APONTIS PHARMA and Develco Pharma enter development partnership for launch of two Single Pills with pan-European intellectual property rights
05.05.2022 - DGAP-News: APONTIS PHARMA AG / Key word(s): Product Launch APONTIS PHARMA and Develco Pharma enter development partnership for launch of two Single Pills with pan-European intellectual property rights 05.05.2022 / 07:30 The issuer is solely ... Seite 1
20.04.2022 - DGAP-News: APONTIS PHARMA AG / Key word(s): Scientific publication APONTIS PHARMA: START study published in scientific journal - Cost reduction in the treatment of cardiovascular patients by Single Pill therapy 20.04.2022 / 07:30 The issuer is ... Seite 1
16.03.2022 - DGAP-News: APONTIS PHARMA AG / Key word(s): Scientific publication APONTIS PHARMA: START study published in scientific journal - Lower incidence of cardiovascular events with Single Pill therapy 16.03.2022 / 07:30 The issuer is solely responsible ... Seite 1